LAKE ZURICH, Ill. and HACKENSACK, N.J., Jan. 18, 2011
/PRNewswire/ — Fenwal, Inc. of Lake Zurich, Illinois, and
GenesisBPS of Hackensack, N.J., announced today they have signed an
agreement under which Fenwal will co-market and distribute a range
of Genesis-branded products for blood centers, plasma centers and
hospitals in the United States and Canada.
The agreement covers products such as Genesis™ blood
collection mixers and monitors, RapidSeal II™ tube sealers
and automated plasma expressers. Genesis products are designed to
help operators improve precision and accuracy in the collection,
separation, preparation and storage of blood components.
Fenwal is a global medical technology company focused on
improving blood collection, separation, safety and availability. It
offers the broadest range of technologies and supplies used in
blood collection and transfusion medicine.
“This agreement further expands the Fenwal product offering and
enhances the value we bring blood and plasma centers in North
America,” said Dean Gregory, Fenwal senior vice president of
“Fenwal brings high standards for service excellence and
extensive knowledge in serving blood and plasma centers,” said Adam
Grossman, executive vice president of GenesisBPS. “Customers will
benefit from the enhanced support and one-stop convenience this
Fenwal will exclusively market and distribute GenesisBPS
products to community blood centers and plasma collection centers.
GenesisBPS will market and distribute direct to the American Red
Cross and U.S. government organizations, and both companies will
service hospital accounts.
Fenwal, Inc. is a global medical technology company focused on
improving blood collection, filtration, separation, storage and
transfusion to ensure the availability, safety and effectiveness of
blood components. Fenwal is unique in the depth of its